Murat Emül - Publications, H-index & Citations

Murat Emül

istanbul university - cerrahpasa

18H指数

129论文数

1.1K被引数

收录论文 51

发表时间

Psychiatric Decompensation Following AI Chatbot Use in Autism Spectrum Disorder

Asian Journal of Psychiatry

IF4.5

2026-02-07

PREAI

Idris Altinisik; Hamiyet Ipek; Zubeyde Sisman; Murat Emul

White matter changes and its relationship with clinical symptom in medication-naive first-episode early onset schizophrenia

ASIAN JOURNAL OF PSYCHIATRY

IF4.5

2023-09-01

PREAI

Ulukorkut, Samil; Ulukorkut, Zeliha Cepik; Emul, Murat

Detecting biomarkers associated with antipsychotic-induced extrapyramidal syndromes by using machine learning techniques 通过使用机器学习技术检测与抗精神病药引起的锥体外系综合征相关的生物标志物

JOURNAL OF PSYCHIATRIC RESEARCH

IF3.2

2023-02-01

PREAI

Kalelioglu, Tevfik; Karamustafalioglu, Nesrin; Emul, Murat; Celikel, Guler; Ozonder, Ipek; Kara, Aysu; Kilic, Cenk; Yalcin, Suat; Celik, Ecem; Kilic, Ugur; Ladoni, Ahoora; Ragone, Emma; Centeno, Caroline; Penberthy, J. Kim

The neutrophil and platelet to lymphocyte ratios in people with subjective, mild cognitive impairment and early Alzheimer's disease

EUROPEAN PSYCHIATRY

IF6.7

2020-03-23

PREAI

Kalelioglu, T.; Yuruyen, M.; Gultekin, G.; Yavuzer, H.; Ozturk, Y.; Kurt, M.; Topcu, Y.; Doventas, A.; Emul, M.

Serum osmolarity and blood viscosity in neuroleptic malignant syndrome

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2019-01-01

PREAI

Celikel, G.; Kalelioglu, T.; Karamustafalioglu, N.; Genc, A.; Emul, M.

Effect of mood on serum osmolarity: a comparison between manic, depressive and mixed states of bipolar disorder

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2019-01-01

PREAI

Celik, E.; Celikel, G.; Kalelioglu, T.; Karamustafalioglu, N.; Genc, A.; Emul, M.

Comment on Diabetes mellitus and first episode mania associated with cardiovascular diseases in patients with older age bipolar disorder

PSYCHIATRY RESEARCH

IF3.9

2018-04-01

PREAI

Kalelioglu, Tevfik; Karamustafalioglu, Nesrin; Genc, Abdullah; Emul, Murat

Cognitive impairment and plasma phoenixin level

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2017-10-01

PREAI

Gultekin, G.; Batun, G. C.; Yuruyen, M.; Yavuzer, H.; Akcan, F. E.; Emul, M.

Does plasma phoenixin level associate with cognition? Comparison between subjective memory complaint, mild cognitive impairment, and mild Alzheimer's disease

INTERNATIONAL PSYCHOGERIATRICS

IF4.3

2017-09-01

PREAI

Yuruyen, Mehmet; Gultekin, Gozde; Batun, Gizem Cetiner; Yavuzer, Hakan; Akcan, Fundan Engin; Doventas, Alper; Emul, Murat

Alexithymia in people with subjective cognitive decline, mild cognitive impairment, and mild Alzheimer's disease 主观认知下降，轻度认知障碍和轻度阿尔茨海默氏病患者的述情障碍

AGING CLINICAL AND EXPERIMENTAL RESEARCH

IF3.4

2017-01-21

PREAI

Yuruyen, Mehmet; Akcan, Fundan Engin; Batun, Gizem Cetiner; Gultekin, Gozde; Toprak, Mesut; Yavuzer, Hakan; Emul, Murat

Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics

PSYCHIATRY RESEARCH

IF3.9

2017-01-01

PREAI

Bas, Alper; Gultekin, Gozde; Incir, Said; Bas, Tuba Ocek; Emul, Murat; Duran, Alaatin

Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-01

PREAI

Balcioglu, Y. H.; Kalelioglu, T.; Durak, N.; Karamustafalioglu, N.; Genc, A.; Emul, M.

Comparing the soluble urokinase-type plasminogen activator receptor (suPAR) levels between individuals with subjective cognitive decline and mild cognitive impairment

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-01

PREAI

Batun, G. Cetiner; Gultekin, G.; Yuruyen, M.; Yavuzer, H.; Armutcu, F.; Emul, M.; Kocabasoglu, N.

Comparison of serum tumor necrosis factor-like weak inducer of apoptosis levels in patients with schizophrenia and healthy control subjects

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-01

PREAI

Ozkal, U.; Gultekin, G.; Incir, S.; Emul, M.; Konuk, N.

Assessment of cardiovascular risk via atherogenic index of plasma (AIP) and atherogenic coefficient (AC) in patients with bipolar disorder

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-01

PREAI

Emul, M.; Kalelioglu, T.; Karamustafalioglu, N.; Genc, A.; Genc, E.; Akkus, M.

Comparison of the activity of brain-derived neurotrophic factor in patients with schizophrenia before and after electroconvulsive therapy

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-01

PREAI

Zakirov, F.; Yuksek, E.; Incir, S.; Saglam, N. G. Usta; Zakirova, B. Kalayci; Emul, M.

Schizophrenia and fragmented QRS

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-01

PREAI

Genc, A.; Cetin, S.; Yuksek, E.; Tasdemir, A.; Akkus, M.; Kalelioglu, T.; Genc, E. S.; Karamustafalioglu, N.; Emul, M.

Comparing the nesfatin-1 levels between individuals with subjective cognitive decline and mild cognitive impairment

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-01

PREAI

Gultekin, G.; Batun, G. C.; Yuruyen, M.; Yavuzer, H.; Akcan, F. E.; Armutcu, F.; Tosun, M.; Emul, M.

Polysubstance use and fragmented QRS

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-01

PREAI

Akkus, M.; Cetin, S.; Genc, A.; Kalelioglu, T.; Zakirov, F.; Guliyev, E.; Balcioglu, Y. H.; Karamustafalioglu, N.; Emul, M.

Association between inflammation, oxidative stress and clinical features of bipolar disorder manic episode

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-01

PREAI

Karamustafalioglu, N.; Kalelioglu, T.; Genc, A.; Akkus, M.; Genc, E.; Emul, M.

研究方向